title: Autoimmune response as a side effect of treatment with interferon-α in melanoma: does this have prognostic implications?
authors.affiliation: Department of Dermatology, University Hospital of Salamanca, Salamanca, Spain. ipalacios@alumni.unav.es.
authors.forename: Irene
authors.initials: I
authors.lastname: Palacios-Álvarez
authors.forename: Concepción
authors.initials: C
authors.lastname: Román-Curto
authors.forename: José M
authors.initials: JM
authors.lastname: Mir-Bonafé
authors.forename: Javier
authors.initials: J
authors.lastname: Cañueto
authors.forename: Teresa
authors.initials: T
authors.lastname: Usero-Bárcena
authors.forename: Emilia
authors.initials: E
authors.lastname: Fernández-López
mesh_terms: D005260:Female; D006111:Graves Disease / Q000139:chemically induced*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D016898:Interferon-alpha / Q000009:adverse effects*; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014820:Vitiligo / Q000139:chemically induced*
chemical_list: D007155:Immunologic Factors; D016898:Interferon-alpha